Publications
Roy S, Sun Y, Eastham JA, Gleave M, Wallis CJD, Beltran HA, Kishan AU, Jia AY, Zaorsky NG, Nagar H, Garcia JA, Small EJ, Nguyen P, Attard G, McKay RR, Sartor O, Berlin A, Rosenthal SA, Halabi S, Vince R, Ponsky L, Morgan SC, Hannan R, Raben A, Roach M, Michalski JM, Morris MJ, Sandler HM, Spratt DE. Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer. European urology oncology. 2025. PMID: 40683825
Minichiello V, Ring M, Adler SR, Bora S, Chiasson AM, Garber TS, Dhruva A, Hu K, Kogan M, Kohatsu W, Dog TL, Mehta DH, Rindfleisch A, Schneiderhan J, Soriano S. Reimagining integrative medicine fellowship core competencies with a health equity lens. The American journal of medicine. 2025. PMID: 40681011
Brooks TR, Zabor EC, Bedelu Y, Yang X, Karimi YH, Nedved AN, Wang Y, Dave NK, Landsburg DJ, Baron K, Hu B, Trotier D, Pophali PA, Miller J, Grover NS, Reinert C, Major A, Schwarz T, Patel K, Salafian K, Ayers EC, Sundaram S, Brody JD, McKenna M, Tiger YKR, Sears-Smith M, Ghosh N, Peterson C, Khan C, Bliven SP, Narkhede M, Gibson A, Kline J, Munoz J, Garza Morales R, Ho C, Smith SD, Niu A, Hernandez-Ilizaliturri FJ, Chinyengetere F, Dave SS, Abdel-Razeq N, Alhaj Moustafa M, Caimi P, Hill BT. Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Blood. 2025. PMID: 40663785
Schinke C, Touzeau C, Oriol A, Mateos MV, Stevens D, Rasche L, Qin X, Kato K, Bathija S, Katz EG, Gries KS, Campagna M, Masterson T, Hilder BW, Tolbert J, Renaud T, Heuck C, Tomlinson C, Moreau P, San-Miguel J, Rodríguez-Otero P, Chari A. Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study. Cancer. 2025. PMID: 40631904
Hertz DL, Venook AP. Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing. JCO precision oncology. 2025. PMID: 40638877
LeVee A, Deutsh A, Lindgren ES, Yan R, Moore H, Pasricha ND, Leventhal J, Dent S, Rugo HS. New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2025. PMID: 40632949
Zhang Y, Lev-Ari S, Zaemes J, Della Pia A, DeAgresta B, Gupta S, Marki A, Zemel R, Ip A, Alaoui A, Charalampous C, Rahman I, Wilkins O, Madhavan S, McGarvey P, Pascual L, Atkins MB, Shah NJ. Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions. JAMIA open. 2025. PMID: 40636413
Wong MK, Milhem MM, Sacco JJ, Michels J, In GK, Couselo EM, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Wise-Draper TM, Bowles TL, Tsai KK, Lebbé C, Gaudy-Marqueste C, Middleton MR, Skolariki A, Samson A, Chesney JA, VanderWalde AM, Zakharia Y, Harrington KJ, Appleton E, Bommareddy PK, Zhu J, Viana M, Hou JW, Coffin RS, Robert C. RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025. PMID: 40627813
Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara P, Foye A, Ryan CJ, Quigley DA, Huang J, Aggarwal R, Reiter RE, Wicha MS, Beer TM, Rettig M, Gleave M, Evans CP, Witte ON, Stuart JM, Thomas GV, Feng FY, Small EJ, Xia Z, Alumkal JJ. Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer. NPJ precision oncology. 2025. PMID: 40624104
Kwarteng LA, Lee AY, Sakafu L, Mango VL, Fundikira LS, Lyimo F, Kwikima U, Mushi BP, Van Loon K, Minja FJ. Global radiology: Building equitable and effective partnerships with low and middle-income countries. Clinical imaging. 2025. PMID: 40633489
Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara P, Foye A, Ryan CJ, Quigley DA, Huang J, Aggarwal R, Reiter RE, Wicha MS, Beer TM, Rettig M, Gleave M, Evans CP, Witte ON, Stuart JM, Thomas GV, Feng FY, Small EJ, Xia Z, Alumkal JJ. Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer. NPJ precision oncology. 2025. PMID: 40624104
Le P, Ung L, Yang H, Huang A, He T, Bruno P, Oh DY, Keenan BP, Zhang L. PepTCR-Net: prediction of multi-class antigen peptides by T-cell receptor sequences with deep learning. Briefings in bioinformatics. 2025. PMID: 40702702
Le P, Ung L, Yang H, Huang A, He T, Bruno P, Oh DY, Keenan BP, Zhang L. PepTCR-Net: prediction of multi-class antigen peptides by T-cell receptor sequences with deep learning. Briefings in bioinformatics. 2025. PMID: 40702702
Miller CR, Huang Y, Allan JN, Bhat SA, Bond D, Brander D, Byrd JC, Chavez J, Chong E, Danilov A, Dowling MR, Dvorak-Kornaus K, Hampel PJ, Ho C, Islam P, Malakhov N, Matasar M, Miller S, Parikh SA, Rabe KG, Rhodes JM, Roeker LE, Rogers KA, Saha A, Skarbnik A, Scott H, Schade J, Shadman M, Shouse G, Stephens DM, Thompson MC, Thompson PA, Wang Y, Woyach JA, Yano M, Omer Z, Kittai AS. Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. American journal of hematology. 2025. PMID: 40600589
Kennedy VE, Ahmed N, Artz A, Bhatt NS, Custatis R, Espinoza-Gutarra MR, Farhan S, Ferguson RJ, Hamilton B, Katz H, Kelly DL, Knight JM, Lee C, Lin A, Lin R, Mohanraj L, Munshi P, Nawas M, Nelson AM, Odstracil S, Olin R, Phelan R, Rentscher KE, Schoemans H, Sung A, Taylor MR, Wood W, Yuen CH, Jayani-Kosarzycki RV. Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Transplantation and cellular therapy. 2025. PMID: 40614969
Chen HY, de Kouchkovsky I, Bok RA, Ohliger MA, Wang ZJ, Gebrezgiabhier D, Nickles T, Carvajal L, Gordon JW, Larson PEZ, Kurhanewicz J, Aggarwal R, Vigneron DB. Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic Hyperpolarized 13C MRI-A Correlative Study with Clinical Outcomes. Cancers. 2025. PMID: 40647509
Layman RM, Han HS, Rugo HS, Stringer-Reasor EM, Specht JM, Dees EC, Kabos P, Suzuki S, Mutka SC, Sullivan BF, Gorbatchevsky I, Wesolowski R. Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy. The Lancet. Oncology. 2025. PMID: 40609573
Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A, Peritoneal Surface Malignancies Consortium Group. Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Cancer. 2025. PMID: 40558053
Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L, Wilcox M, Hope W, Leonard C, Howard P, Jenkins D, Ashworth A, Bentley A, Sculpher M. Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England. Applied health economics and health policy. 2025. PMID: 40455404
Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, Orloff G, Jakubowiak A, Niesvizky R, Liles D, Berdeja J, Levy M, Wolf J, Usmani SZ, MMRF CoMMpass Network, Christofferson AW, Nasser S, Aldrich JL, Legendre C, Benard B, Miller C, Turner B, Kurdoglu A, Washington M, Yellapantula V, Adkins JR, Cuyugan L, Boateng M, Helland A, Kyman S, McDonald J, Reiman R, Stephenson K, Tassone E, Blanski A, Livermore B, Kirchhoff M, Rohrer DC, D'Agostino M, Gambella M, Collison K, Stumph J, Kidd P, Donnelly A, Zaugg B, Toone M, McBride K, DeRome M, Rogers J, Craig D, Liang WS, Gutierrez NC, Jewell SD, Carpten J, Anderson KC, Cho HJ, Auclair D, Lonial S, Keats JJ. Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nature genetics. 2025. PMID: 40490515